TMED3 and neoplasm: The results suggested that TMED3 protein expression was significantly upregulated in 52.1% of melanoma specimens (87/167), while the majority of 30 non-tumor samples exhibited low TMED3 levels (29/30) (Fig. 1A and Table 1).